2026 Research Updates Available

Independent peptide research and evidence-based analysis

Comprehensive, peer-reviewed peptide research compiled from PubMed, Nature, the American Peptide Society, and leading scientific journals. Every claim is evidence-tiered and independently sourced.

Research laboratory
About Our Research

Evidence-based analysis you can trust

We aggregate and analyze peptide research from the world's leading scientific publications. Our mission is to provide independent, non-commercial, evidence-based information about peptide therapeutics for researchers, clinicians, and the scientifically curious.

Every peptide profile on this site includes its evidence tier (FDA-approved, clinical trial, or preclinical), mechanism of action, key research findings, safety data, and direct citations to peer-reviewed publications.

Peer-Reviewed Citations
Evidence-Tiered Classification
Regular Updates
Browse Research Library
Our Process

Research Methodology

Research process steps
01

Literature Review

Systematic review of peer-reviewed publications from PubMed, Nature, and leading peptide journals

02

Evidence Classification

Each peptide is classified by evidence tier: FDA-approved, clinical trials, or preclinical research

03

Expert Analysis

Mechanisms of action, safety profiles, and research applications are comprehensively documented

04

Continuous Updates

Content is regularly updated as new research findings and regulatory changes emerge

Comprehensive evidence-based peptide research

Aggregating data from leading scientific publications worldwide

Explore Categories
Research quality
Why Choose Us

Smart choices for evidence-based research

Our research platform aggregates and classifies peptide data from the world's leading scientific journals, providing researchers and professionals with a comprehensive, evidence-tiered resource.

Our Methodology
80+
Peptides Catalogued
500+
Studies Cited
7
Research Categories
2026
Data Current To
Expert Insights

What our researchers say

Peptide therapeutics represent one of the most promising frontiers in modern medicine. From immune modulation with thymosin alpha-1 to the metabolic breakthroughs of GLP-1 agonists, we are only beginning to understand the therapeutic potential of these molecules.

Dr. Allan Goldstein

Professor Emeritus, Biochemistry - George Washington University

Dr. Allan Goldstein

Trusted Scientific Sources

Our research draws from the world's leading peptide science publications and databases

PubMed / NIHNatureAmerican Peptide SocietyPeptides (Elsevier)FrontiersACS Publications

Why Independent Peptide Research Matters

The peptide therapeutics landscape is rapidly evolving. With the FDA reviewing multiple peptides for reclassification in 2026, and new research emerging from institutions worldwide, having a reliable, non-commercial source of scientific information has never been more important.

Our content is compiled from publications indexed in PubMed/NIH, the American Peptide Society, Nature, Frontiers in Aging, Peptides (Elsevier), and other peer-reviewed journals. We do not sell products, provide medical advice, or recommend treatments.